BiotechTube

Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040)

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Contraceptive

Conditions

Contraceptive

Trial Timeline

Aug 26, 2019 → Feb 17, 2022

NCT ID
NCT03901131

About Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040)

Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040) is a pre-clinical stage product being developed by Bayer for Contraceptive. The current trial status is completed. This product is registered under clinical trial identifier NCT03901131. Target conditions include Contraceptive.

What happened to similar drugs?

0 of 5 similar drugs in Contraceptive were approved

Approved (0) Terminated (0) Active (5)
🔄Levonorgestrel 90 mg and Ethinyl Estradiol 20 mgPfizerPhase 3
🔄EE20/DRSP (YAZ, BAY86-5300) + Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)BayerPhase 3
🔄EV/DNG (Qlaira, BAY86-5027) + Encapsulated Microgynon + PlaceboBayerPhase 3
🔄Valette (Dienogest/EE30, BAY86-5038) + Valette (Dienogest/EE30, BAY86-5038)BayerPhase 3
🔄Etonogestrel contraceptive implantBayerPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03901131Pre-clinicalCompleted

Competing Products

13 competing products in Contraceptive

See all competitors
ProductCompanyStageHype Score
AZD1981 + Neovletta 21/28 + Placebo AZD1981AstraZenecaPhase 1
29
fostamatinib + Microgynon® 30 (Oral contraceptive) + PlaceboAstraZenecaPhase 1
29
Leios/AlessePfizerPre-clinical
26
Levonorgestrel 90 mg and Ethinyl Estradiol 20 mgPfizerPhase 3
40
EE20/DRSP (YAZ, BAY86-5300) + Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)BayerPhase 3
37
EV/DNG (Qlaira, BAY86-5027) + Encapsulated Microgynon + PlaceboBayerPhase 3
37
SH T04769G + Ethinyl estradiol / dienogest (SH D00659 AF)BayerPhase 2
32
E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) + E2/DRSP (BAY 86-4891) dose 2 (80458739) + E2/DRSP (BAY 86-4891) dose 3 (80458755) + E2/DRSP (BAY 86-4891) dose 4 (80458720) + E2/DRSP (BAY 86-4891) dose 5 (80458712) + DRSP (ZK 30595) dose 1 (SH T04984F) + DRSP (ZK 30595) dose 2 (80458690) + PlaceboBayerPhase 2
32
Valette (Dienogest/EE30, BAY86-5038) + Valette (Dienogest/EE30, BAY86-5038)BayerPhase 3
37
EV/DNG (Qlaira, BAY86-5027) + Progestin Only PillsBayerPre-clinical
23
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) + Yasminelle (SH T 00186 D)BayerPhase 2
32
Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2BayerPhase 1
26
Etonogestrel contraceptive implantBayerPhase 3
37